James Trager, Chief Scientific Officer at Nkarta, Inc. (NKTX), sold 10,000 shares at $38.07 ($390K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $390k NKTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.07 | 2,034 | $77K | 19.8% |
| 2 | $38.07 | 2,034 | $77K | 19.8% |
| 3 | $39.46 | 1,566 | $62K | 15.8% |
| 4 | $39.46 | 1,566 | $62K | 15.8% |
| 5 | $40.00 | 2,800 | $112K | 28.7% |
| Total | $39.05 avg | 10,000 |
| $390K |
| 100% |
| Filing → |
| NKTX | SELL | 2024-01-18 | $40K | — | Filing → |
| NKTX | SELL | 2023-06-22 | $2K | — | Filing → |
| NKTX | SELL | 2023-01-18 | $6K | — | Filing → |